Skip to main content
Back to Investments

Ellab

Status
Realised
Country
Denmark
Strategy
Mid Cap
Entry
Aug-16
Exit
Aug-19
Fund
IK VIII
Website

Global leader in thermal validation equipment for the pharma, food and hospital sectors

At the time of exiting, Ellab was a leading global supplier of solutions for measuring, recording, monitoring and validating critical parameters of thermal processing, selling its products in over 65 countries across the globe.

The company offered a wide product range of high-precision systems for temperature, pressure and humidity monitoring and validation based on either data loggers or wired thermocouple instruments.

Ellab’s products were used by the pharmaceutical and food industry as well as hospitals, where accurate and complete supporting validation documentation is essential.

Ellab was acquired by IK from the Founders in August 2016 via the IK VIII Fund. Ellab was subsequently sold to EQT in August 2019.

Our Value Creation Strategy

During our ownership, we worked alongside the management team to:

  • Promote continued organic growth through further market share gains in the pharma segment;
  • Invest in organic expansion of the validation services market;
  • Investigate the merits of entering adjacent validation industry verticals; and
  • Pursue growth through M&A of identified targets.